Export Restrictions On Surgical Ai Systems.

Export Restrictions on Surgical AI Systems

1. Introduction

Export restrictions on surgical artificial intelligence (AI) systems refer to legal controls imposed on the international transfer, sale, licensing, software distribution, technical assistance, and provision of technology associated with AI-enabled surgical equipment.

Surgical AI systems may include robotic surgical platforms, AI-assisted imaging and navigation systems, autonomous surgical instruments, remote surgery technologies, machine-learning models used during operations, and software that supports intraoperative decision-making.

These technologies can improve surgical precision and access to healthcare, but some also possess potential military, intelligence, cybersecurity, or dual-use applications. Export restrictions therefore seek to balance national security, public health, technological sovereignty, international trade, and patient safety.

Export controls are not necessarily a blanket prohibition on exporting surgical AI. Their application depends on the system's technical specifications, intended use, destination, end user, software, technical data, and applicable national laws.

2. Major Grounds for Export Restrictions

A. National security and dual-use technology

Certain surgical AI components may overlap with technologies used in military robotics, advanced sensing, autonomous systems, high-performance computing, or specialized machine-learning applications. Governments may restrict transfers where the relevant technology falls within controlled categories or could contribute to military capabilities.

However, a medical purpose alone does not determine whether a product is controlled, and the mere use of AI does not automatically make a surgical system subject to export restrictions.

B. Protection of sensitive technical information

Export controls may cover more than physical surgical robots. Depending on the applicable law, restrictions can extend to:

Technical drawings, source code, and specialized software.

AI model weights, training methods, or controlled technical datasets.

Remote access to restricted technology.

Technical assistance, training, and maintenance provided to foreign persons.

Transfers to foreign subsidiaries, research institutions, or other recipients.

A company must therefore assess both the physical equipment and the associated intangible technology.

C. Prevention of unauthorized military or surveillance use

A surgical robot supplied to a legitimate hospital may present a different risk from an identical system intended for a military research programme or a sanctioned entity. Export licensing systems may assess the recipient, end use, diversion risk, and destination.

Companies should conduct appropriate end-user screening, obtain end-use declarations where necessary, investigate suspicious intermediaries, and establish contractual controls against unauthorized diversion.

D. Patient safety and cybersecurity

Surgical AI systems depend on software updates, remote diagnostics, network connectivity, and sometimes cloud-based models. Exporting an inadequately tested system may expose patients to unreliable clinical performance or cybersecurity threats.

Nevertheless, clinical safety regulation and export control are distinct legal regimes. A device's medical approval does not automatically authorize its export, and an export licence does not establish that the device is clinically safe.

3. Applicable Legal Frameworks

A. India: Foreign Trade (Development and Regulation) Act, 1992 and SCOMET

India regulates specified strategic and dual-use exports through the Foreign Trade (Development and Regulation) Act, 1992, the Foreign Trade Policy 2023, and the SCOMET (Special Chemicals, Organisms, Materials, Equipment and Technologies) list.

The Directorate General of Foreign Trade (DGFT) administers the SCOMET framework, with licensing responsibilities allocated according to the relevant category and applicable rules. The official 2025 SCOMET list includes specified controlled technologies and equipment, but an ordinary medical robot is not automatically controlled merely because it performs surgery. Classification must be based on the applicable entry and technical specifications.

Press Information Bureau

+1

 

For an Indian surgical AI exporter, the principal compliance steps are:

Determine whether the equipment, software, or technology falls within a SCOMET entry.

Identify the destination, consignee, end user, and intended end use.

Obtain the required authorization before export when applicable.

Maintain accurate technical classifications, licences, and transaction records.

Check any separate sanctions, customs, and medical-device requirements.

B. United States: Export Administration Regulations

The US Export Administration Regulations (EAR), administered by the Bureau of Industry and Security (BIS), govern specified exports, reexports, and transfers of commodities, software, and technology subject to US jurisdiction.

A surgical AI system may be classified as EAR99 or under a particular Export Control Classification Number (ECCN), depending on its characteristics and applicable rules. Certain transactions may require a licence because of the destination, restricted party, or intended end use even when the equipment is marketed as a medical device.

For example, the EAR's medical-device licence exception contains specific limitations relating to certain destinations and prohibited end users. It does not create a universal exemption for all medical equipment.

Bureau of Industry and Security

+1

 

C. European Union: Regulation (EU) 2021/821

The EU Dual-Use Regulation establishes controls for specified goods, software, and technology capable of civilian and military use. It also provides for end-use controls, technical-assistance controls, and authorisation requirements.

A surgical AI system may require authorization if it falls within a listed control category or if applicable catch-all provisions or sanctions apply. The assessment depends on the precise product and transaction; the medical purpose alone does not settle the question.

Trade and Economic Security

 

D. Wassenaar Arrangement

The Wassenaar Arrangement coordinates participating states' export-control policies for conventional arms and dual-use goods and technologies. Its control lists inform national regulations, but the Arrangement does not itself issue export licences or operate as a directly enforceable global licensing statute. National implementation determines the applicable legal obligations.

The Wassenaar Arrangement

+1

 

4. Important Case Laws

There appears to be no leading reported judgment specifically deciding the export restrictions applicable to an AI-powered surgical robot. The following cases provide relevant principles by analogy.

1. Fritz Werner Industrie-Ausrüstungen GmbH v. Federal Republic of Germany (1995)

Citation: Case C-70/94, ECLI:EU:C:1995:328.

The Court of Justice of the European Communities considered export restrictions involving goods capable of military use. It addressed the relationship between export licensing, the common commercial policy, and public security.

Legal principle: Export restrictions on dual-use goods can be justified on public-security grounds within the applicable legal framework.

Application: If a surgical AI platform incorporates technology controlled because of its military applications, the exporter may need authorization despite its intended civilian medical use. However, the authority must apply the relevant classification and licensing rules rather than presume that every surgical robot is a dual-use controlled item.

EUR-Lex

+1

 

2. United States v. Edler Industries, Inc. (1978)

Citation: 579 F.2d 516 (9th Cir. 1978).

The US Court of Appeals considered the unlicensed transfer of technical information relating to missile technology. The court emphasized that controlled technical information must have a significant and direct relationship to specified military articles; an excessively broad interpretation could improperly restrict scientific and technical exchange.

Legal principle: Export controls on technical information require careful attention to the scope of the controlled category and the relationship between the information and the regulated technology.

Application: Surgical AI companies should distinguish ordinary medical software documentation from technical information specifically controlled under applicable export laws. The case does not establish a general exemption for medical AI, but it illustrates why classification and the scope of technical-data controls matter.

Justia Law

+1

 

3. United States v. Van Hee (1976)

Citation: 531 F.2d 352 (6th Cir. 1976).

This case concerned the export of blueprints and technical expertise for the production of an armored amphibious military vehicle. The court held that the information was subject to export licensing under the legal framework then in force because of its close connection with a controlled military article.

Legal principle: Export restrictions can extend beyond physical products to blueprints, specialized technical expertise, and assistance directly connected with controlled equipment.

Application: An exporter of surgical robotics must assess whether sharing source code, engineering designs, specialized manufacturing instructions, or technical support constitutes a controlled transfer. The precise result under modern law depends on the applicable statutory and regulatory definitions.

5. Ethical Issues in Restricting Surgical AI Exports

A. Right to health and equitable access

Restricting advanced surgical technology may prevent dangerous transfers, but excessive restrictions can also deprive hospitals in lower-income countries of life-saving equipment. Governments should consider humanitarian consequences, legitimate civilian demand, and the availability of licensing exceptions.

B. Transparency and legal certainty

Exporters should be able to determine whether their systems are controlled using published classifications and predictable procedures. Vague or inconsistent restrictions may discourage beneficial medical innovation and international research.

C. Proportionality and non-discrimination

Restrictions should address identifiable security risks without unnecessarily blocking ordinary medical devices or disproportionately disadvantaging particular countries or populations. Risk-based licensing and clearly defined humanitarian pathways can help reconcile security with healthcare access.

D. Corporate responsibility

Manufacturers should maintain export-compliance programmes, evaluate end users, protect controlled technical information, and investigate diversion risks. They should also avoid misleading hospitals about the legal availability, safety, or permitted uses of exported systems.

6. Conclusion

Export restrictions on surgical AI systems are governed by a combination of strategic-trade controls, national security laws, sanctions, technical classification rules, and medical-device regulation. The principal challenge is distinguishing ordinary medical technology from equipment or technical information that falls within a legally controlled category.

The cases Fritz Werner, Edler Industries, and Van Hee illustrate three important principles: public security can justify certain export restrictions, controlled technical information may be regulated alongside physical goods, and export controls should be applied within clearly defined legal boundaries.

For India, the practical starting point is the SCOMET classification and the applicable DGFT licensing framework. For US- or EU-connected transactions, the EAR or EU Dual-Use Regulation may also apply, depending on the facts.

Ultimately, effective regulation should prevent dangerous diversion of surgical AI without imposing unnecessary barriers to legitimate medical innovation and access to healthcare.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT